Back
Avista Vs. Akero Therapeutics Industry Stock Comparison
Buy
60
AVA
Avista
Last Price:
$37.33
Seasonality Move:
-1.05%
Sell
40
AKRO
Akero Therapeutics
Last Price:
$51.83
Seasonality Move:
25.71%
Sell
40
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $51.88. The Score for AKRO is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
AKRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AVA Stock Price Chart
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $51.88The current trend is moderately bearish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
AVA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 49.75 | Sell |
Chaikin Money Flow: | -525493 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (37.43 - 38.19) | Buy |
Bollinger Bands (100): | (37.78 - 40.82) | Sell |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.22 | Buy |
Relative Strength Index (14 RSI): | 49.26 | Sell |
Chaikin Money Flow: | 662054 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (51.41 - 54.87) | Sell |
Bollinger Bands (100): | (40.17 - 52.31) | Buy |
AVA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 37.71 | Buy |
20-day SMA: | 37.9 | Buy |
50-day SMA: | 38.03 | Sell |
200-day SMA: | 38.28 | Sell |
8-day EMA: | 37.74 | Buy |
20-day EMA: | 37.85 | Buy |
50-day EMA: | 38.24 | Sell |
200-day EMA: | 38.27 | Sell |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 52.42 | Sell |
20-day SMA: | 52.71 | Sell |
50-day SMA: | 50.4 | Buy |
200-day SMA: | 40.07 | Buy |
8-day EMA: | 52.25 | Sell |
20-day EMA: | 52.35 | Sell |
50-day EMA: | 50.45 | Buy |
200-day EMA: | 41.77 | Buy |
Avista Earnings Growth & AVA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.09 per share, an increase this year of $0.23 per share, and an increase next year of $0.19 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.17 per share, and a decrease next year of $0.64 per share.
Avista Technical Analysis
Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |